Lista de obras - Leszek Tylicki - Dominio Público Uruguay

Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease

artículo científico publicado en 2012

Aliskiren attenuates oxidative stress and improves tubular status in non-diabetic patients with chronic kidney disease-Placebo controlled, randomized, cross-over study

artículo científico publicado en 2014

Aliskiren reduces albuminuria after kidney transplantation.

artículo científico publicado en 2017

Antioxidants: a possible role in kidney protection

artículo científico publicado en 2003

Atorvastatin attenuates oxidative stress in patients with chronic kidney disease.

artículo científico publicado en 2010

Atorvastatin improves tubular status in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.

artículo científico publicado en 2010

Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs--pilot study

artículo científico publicado en 2001

Blood coagulation unaffected by ozonated autohemotherapy in patients on maintenance hemodialysis

scientific article published on 01 November 2006

Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Renal Transplant Recipients

scientific article published on 13 March 2018

Clinical efficacy of ozonated autohemotherapy in hemodialyzed patients with intermittent claudication: an oxygen-controlled study

scientific article published on 01 January 2004

Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline

artículo científico publicado en 2008

Combination treatment and renal function in patients with chronic kidney disease

artículo científico publicado en 2010

Dietary supplement use among patients with chronic kidney disease

artículo científico publicado en 2018

Direct renin inhibition--a promising strategy for renal protection?

artículo científico

Dual blockade of the renin-angiotensin-aldosterone system in renal disease: what is the future? Authors' reply

Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study.

artículo científico publicado en 2008

Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial

artículo científico publicado en 2012

Effect of pentoxifylline on proteinuria, markers of tubular injury and oxidative stress in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.

artículo científico publicado en 2010

Effects of N-acetylcysteine on angiotensin-converting enzyme plasma activity in patients with chronic kidney diseases.

artículo científico publicado en 2008

Fistula function and dialysis adequacy during ozonotherapy in chronically hemodialyzed patients

scientific article published on 01 May 2004

Gastrointestinal Pathologies in Patients After Successful Renal Transplantation

artículo científico publicado en 2020

Gastrointestinal Pathologies in Patients After Successful Renal Transplantation-A Pilot Study

artículo científico publicado en 2016

High-dose angiotensin-converting enzyme inhibitor attenuates oxidative stress in patients with chronic kidney disease.

artículo científico publicado en 2008

Hypertensive nephropathy - an increasing clinical problem

artículo científico publicado en 1999

Hypertensive nephropathy: pathogenesis, diagnosis and treatment

artículo científico publicado en 2003

Improvement of Blood Pressure Control in Renal Transplant Recipients-Retrospective Longitudinal Study.

artículo científico publicado en 2018

Influence of Renin-Angiotensin System Blockers on Graft Function in Retrospective Analysis of Pairs of Renal Transplant Recipients From the Same Donor

scientific article published on 13 March 2018

Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.

artículo científico publicado en 2004

Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.

artículo científico publicado en 2005

Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis

artículo científico publicado en 2004

Management of Renin-Angiotensin-Aldosterone System Blockade in Kidney Transplant Recipients

artículo científico publicado en 2018

Management of renin-angiotensin system blockade in patients with chronic kidney disease under specialist care. Retrospective cross-sectional study.

artículo científico publicado en 2014

Metabolic disturbances as strong determinator of kidney injury in essential hypertension

artículo científico publicado en 2005

Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension relation: with the development of hypertensive end-stage renal disease.

artículo científico publicado en 2005

Multifactoral analysis of determinators for renal injury in essential hypertension

artículo científico publicado en 2006

Multifactorial determination of hypertensive nephroangiosclerosis.

artículo científico publicado en 2002

Natural killer cell activity unaffected by ozonated autohemotherapy in patients with end-stage renal disease on maintenance renal replacement therapy.

artículo científico publicado en 2004

Nephroprotective action of renin-angiotensin-aldosterone system blockade in chronic kidney disease patients: the landscape after ALTITUDE and VA NEPHRON-D trails

artículo científico

No effects of ozonated autohemotherapy on inflammation response in hemodialyzed patients

artículo científico publicado en 2004

Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease.

artículo científico publicado en 2016

Ozonated autohemotherapy in patients on maintenance hemodialysis: influence on lipid profile and endothelium.

artículo científico publicado en 2004

Ozone therapy seems to be safe, but is it really clinically effective?

artículo científico publicado en 2004

Ozonetherapy in a dialyzed patient with calcific uremic arteriolopathy

artículo científico publicado en 2003

Pentoxifylline old drug or new hope for nephrology?

artículo científico publicado en 2008

Platelet function unaffected by ozonated autohaemotherapy in chronically haemodialysed patients.

artículo científico publicado en 2004

Predictors of Humoral Response to mRNA COVID19 Vaccines in Kidney Transplant Recipients: A Longitudinal Study-The COViNEPH Project

artículo científico publicado en 2021

Prevalence and Hypertension Treatment Schedule in Hemodialysis Patients and Renal Transplant Recipients in 2006 and 2014/2016

artículo científico publicado en 2018

Randomized placebo-controlled study on the effects of losartan and carvedilol on albuminuria in renal transplant recipients.

artículo científico publicado en 2006

Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.

artículo científico publicado en 2005

Renal allograft protection with angiotensin II type 1 receptor antagonists

artículo científico publicado en 2007

Renal protective effects of the renin-angiotensin-aldosterone system blockade: from evidence-based approach to perspectives.

artículo científico publicado en 2005

Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions

artículo científico publicado en 2012

Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.

artículo científico publicado en 2002

Safety of enhanced renin-angiotensin-aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease

artículo científico publicado en 2013

Short-term effects of angiotensin II receptor blockade in patients with primary glomerulonephritis: pilot study

artículo científico publicado en 2002

Smoking as a risk factor for renal injury in essential hypertension

scientific article published on 24 April 2006

Spironolactone attenuates oxidative stress in patients with chronic kidney disease.

artículo científico publicado en 2008

The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study.

artículo científico publicado en 2010

The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study

artículo científico publicado en 2008

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

artículo científico publicado en 2011

The enhanced renin-angiotensin-aldosteron system pharmacological blockade--which is the best?

artículo científico publicado en 2012

The influence of ozonated autohemotherapy on oxidative stress in hemodialyzed patients with atherosclerotic ischemia of lower limbs.

artículo científico publicado en 2003

Treatment of Hypertension in Renal Transplant Recipients in Four Independent Cross-Sectional Analyses.

artículo científico publicado en 2018

Treatment of hypertension in chronic kidney disease patients under specialized care: one-center cross-sectional analyses

artículo científico publicado en 2014

Treatment of hypertension in renal transplant recipients

artículo científico publicado en 2003

Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.

artículo científico publicado en 2008

Tubular injury: the first symptom of hypertensive kidney involvement?

artículo científico publicado en 2003

Tubulointerstitial injury: early or late event in the pathogenesis of hypertensive nephropathy?

artículo científico publicado en 2004

Waning Humoral Response after COVID-19 mRNA Vaccination in Maintenance Dialysis Patients and Recovery after a Complementary Third Dose

artículo científico publicado en 2022

[Cyclophosphamide pulse therapy in patients with primary glomerulonephritis]

scientific article published on 01 January 2000

[Health awareness and cooperation with the patient in the therapeutic process in a population of patients with chronic kidney disease in the center of Gdansk]

[Isoprostanes - important marker of the oxidative stress estimation in patients with chronic kidney disease]

artículo científico publicado en 2013

[Pathogenetic and epidemiological aspects of hypertensive nephropathy]

scientific article published on 01 October 2003

Lista de obras de Leszek Tylicki

Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease

Aliskiren attenuates oxidative stress and improves tubular status in non-diabetic patients with chronic kidney disease-Placebo controlled, randomized, cross-over study

Aliskiren reduces albuminuria after kidney transplantation.

Antioxidants: a possible role in kidney protection

Atorvastatin attenuates oxidative stress in patients with chronic kidney disease.

Atorvastatin improves tubular status in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.

Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs--pilot study

Blood coagulation unaffected by ozonated autohemotherapy in patients on maintenance hemodialysis

Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Renal Transplant Recipients

Clinical efficacy of ozonated autohemotherapy in hemodialyzed patients with intermittent claudication: an oxygen-controlled study

Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline

Combination treatment and renal function in patients with chronic kidney disease

Dietary supplement use among patients with chronic kidney disease

Direct renin inhibition--a promising strategy for renal protection?

Dual blockade of the renin-angiotensin-aldosterone system in renal disease: what is the future? Authors' reply

Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study.

Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial

Effect of pentoxifylline on proteinuria, markers of tubular injury and oxidative stress in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.

Effects of N-acetylcysteine on angiotensin-converting enzyme plasma activity in patients with chronic kidney diseases.

Fistula function and dialysis adequacy during ozonotherapy in chronically hemodialyzed patients

Gastrointestinal Pathologies in Patients After Successful Renal Transplantation

Gastrointestinal Pathologies in Patients After Successful Renal Transplantation-A Pilot Study

High-dose angiotensin-converting enzyme inhibitor attenuates oxidative stress in patients with chronic kidney disease.

Hypertensive nephropathy - an increasing clinical problem

Hypertensive nephropathy: pathogenesis, diagnosis and treatment

Improvement of Blood Pressure Control in Renal Transplant Recipients-Retrospective Longitudinal Study.

Influence of Renin-Angiotensin System Blockers on Graft Function in Retrospective Analysis of Pairs of Renal Transplant Recipients From the Same Donor

Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.

Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.

Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis

Management of Renin-Angiotensin-Aldosterone System Blockade in Kidney Transplant Recipients

Management of renin-angiotensin system blockade in patients with chronic kidney disease under specialist care. Retrospective cross-sectional study.

Metabolic disturbances as strong determinator of kidney injury in essential hypertension

Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension relation: with the development of hypertensive end-stage renal disease.

Multifactoral analysis of determinators for renal injury in essential hypertension

Multifactorial determination of hypertensive nephroangiosclerosis.

Natural killer cell activity unaffected by ozonated autohemotherapy in patients with end-stage renal disease on maintenance renal replacement therapy.

Nephroprotective action of renin-angiotensin-aldosterone system blockade in chronic kidney disease patients: the landscape after ALTITUDE and VA NEPHRON-D trails

No effects of ozonated autohemotherapy on inflammation response in hemodialyzed patients

Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease.

Ozonated autohemotherapy in patients on maintenance hemodialysis: influence on lipid profile and endothelium.

Ozone therapy seems to be safe, but is it really clinically effective?

Ozonetherapy in a dialyzed patient with calcific uremic arteriolopathy

Pentoxifylline old drug or new hope for nephrology?

Platelet function unaffected by ozonated autohaemotherapy in chronically haemodialysed patients.

Predictors of Humoral Response to mRNA COVID19 Vaccines in Kidney Transplant Recipients: A Longitudinal Study-The COViNEPH Project

Prevalence and Hypertension Treatment Schedule in Hemodialysis Patients and Renal Transplant Recipients in 2006 and 2014/2016

Randomized placebo-controlled study on the effects of losartan and carvedilol on albuminuria in renal transplant recipients.

Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.

Renal allograft protection with angiotensin II type 1 receptor antagonists

Renal protective effects of the renin-angiotensin-aldosterone system blockade: from evidence-based approach to perspectives.

Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions

Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.

Safety of enhanced renin-angiotensin-aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease

Short-term effects of angiotensin II receptor blockade in patients with primary glomerulonephritis: pilot study

Smoking as a risk factor for renal injury in essential hypertension

Spironolactone attenuates oxidative stress in patients with chronic kidney disease.

The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study.

The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

The enhanced renin-angiotensin-aldosteron system pharmacological blockade--which is the best?

The influence of ozonated autohemotherapy on oxidative stress in hemodialyzed patients with atherosclerotic ischemia of lower limbs.

Treatment of Hypertension in Renal Transplant Recipients in Four Independent Cross-Sectional Analyses.

Treatment of hypertension in chronic kidney disease patients under specialized care: one-center cross-sectional analyses

Treatment of hypertension in renal transplant recipients

Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.

Tubular injury: the first symptom of hypertensive kidney involvement?

Tubulointerstitial injury: early or late event in the pathogenesis of hypertensive nephropathy?

Waning Humoral Response after COVID-19 mRNA Vaccination in Maintenance Dialysis Patients and Recovery after a Complementary Third Dose

[Cyclophosphamide pulse therapy in patients with primary glomerulonephritis]

[Health awareness and cooperation with the patient in the therapeutic process in a population of patients with chronic kidney disease in the center of Gdansk]

[Isoprostanes - important marker of the oxidative stress estimation in patients with chronic kidney disease]

[Pathogenetic and epidemiological aspects of hypertensive nephropathy]